A CLINICAL STUDY OF EFFECT OF PATALA KSHAR IN THE MANAGEMENT OF MUTRAVAGHATA WITH SPECIAL REFERENCE TO BENIGN PROSTATE HYPERPLASIA by Ranjwe, *Nandkishor et al.
ISSN: 2322 - 0902 (P) 
ISSN: 2322 - 0910 (O) 
 IJAPR | March 2016 | Vol 4 | Issue 3  20 
International Journal of Ayurveda  
and Pharma Research 
 
                                                                              Research Article 
 
 
A CLINICAL STUDY OF EFFECT OF PATALA KSHAR IN THE MANAGEMENT OF MUTRAVAGHATA 
WITH SPECIAL REFERENCE TO BENIGN PROSTATE HYPERPLASIA  
Nandkishor Ranjwe1*, Yogesh Badwe2, Umesh Vaidya3 
*1P.G. Scholar, 2Associate Professor, 3Head of Department, Department of Shalya tantra, Bharati Vidyapeeth Deemed 
University College and Hospital of Ayurveda, Katraj-Dhankawadi, Pune, Maharashtra, India.  
ABSTRACT 
Vatashtila described by Acharya Sushruta is very much similar to Benign prostate hyperplasia. No doubt 
that it is disease which is difficult to cure and many times requires surgical intervention. All the other 
treatment modalities in modern science are very costly to cure the BPH. Hence we have to face many 
problems to treat BPH. Reviewing all the things “A clinical study of Patalakshar in the management of 
Mutraghat with special reference to Benign Prostate Hyperplasia” was selected for dissertation. In this 
study Patala kshar given orally to the BPH patients and follow up taken on 0th, 7th and 15th day. 
Tamsulosin was given to control group and follow up taken on same days as trial groups. Then we were 
found that Patala kshar effect is most of similar to modern conservative treatment tamsulosin. On the 
basis of statistical analysis it concluded that Patala kshar is similarly effective to tamsulosin. 
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INTRODUCTION 
The person having, Triades (Dosha, Dhatu and 
Mala) and Agni in normal state. As well as sound mind, 
Atma and all Indriya is called as healthy only Ayurveda 
deals with spiritual aspect of life by including Atma and 
Mana.1 
 It is very difficult to maintain health in day to day 
ultramodern life. While enjoying the advances and 
facilities provided by 21st century era, its loopholes or 
failures are also coming forward. 
 Since time is money for everybody, nobody has 
sufficient time to spare for the care of his health unless 
and otherwise it hamper their daily activities. Also, due to 
today's fast life normal urge like micturation, defecation is 
suppressed that leads to Vegadharana.2  
 Even Sushruta, an eminent surgeon of ancient 
times and today known to the world as the “Father of 
Surgery” has mentioned in his text, the “Sushruta 
Samhita” the importance of health and over all well being. 
Benign prostate hyperplasia is a disease found in 
elderly males which involve hyperplasia of prostatic 
stromal and epithelial cells resulting in formation of 
largely, fairly discrete nodules in the periuretheral region 
of prostate. When sufficiently large nodules compress the 
urethra it causes partial or complete obstruction of 
urethra which intefers the normal flow of urine. It leads to 
the symptoms like urinary resistance, frequent 
micturation, increase risk of urinary tract infection, 
urinary retention. 
  Vatashtheela Vyadhi may have similarity with 
BPH. According to Acharya Sushruta, vitiated Vata and 
Kapha produces hard gland in between Anus and Urinary 
Bladder which causes obstruction of urine and stool. 
In Ayurvedic text, treatment of Vatashteela is not 
specified, but indicated to treat on the basis of 
Mootraghata. Even in the 21st century we are unable to 
provide a single specific drug or medicine for BPH. In 
treatment of BPH watchful waiting is advised along with 
medicinal therapy like alpha blocker but it can be 
associated with side effect like Headache, Dizziness, 
Fatigue, Ejaculatory Dysfunction and 5 alpha reductase 
inhibitors having side effect like Erectile Dysfunction, 
decreased libido etc. In surgical therapy for BPH patient 
may be suffer from complication such as Retrograde 
Ejaculation, Erectile Impotence, Infection, Stricture, and 
Hemorrhage. 
To avoid the complication of surgical therapy old 
people seek a safe and effective treatment for easy life, in 
this condition medicinal treatment can play important 
role.  
Aim  
 The Effect OF Patala Kshar In The Management Of 
Mutraghata With Special Reference To Benign Prostate 
Heperplasia.  
Objectives 
 To study the role of Patala Kshar in management 
of Mutraghata. To collect the literature of Mutraghata 
according to Ayurvedic Samhita and Modern Text. 
Materials and Methods 
Patients were classified into 2 groups. 
Group A – 15 patients for experiment of Patala kshar i.e. 
Trial Group. 
Group B – 15 patients were selected for Tamsulosine 
Hydrochlorde i.e. control Group. Patients were selected 
from OPD and IPD of Shalyatantra department, Bharati 
Ayurved Hospital, Pune 43. After taking proper history the 
diagnosis of BPH was confirmed by per rectal examination. 
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Inclusion Criteria 
 Patient having Mutraghata were randomly selected 
 Selection was irrespective of age, religion and socio-
economical class. 
 Grade I and grade II prostatomegaly patient were 
considered. 
Exclusion criteria 
 Ca. Prostate 
 Diabetes 
 Patient above 80 years  
 Urethral stricture 
 Bladder calculus 
 Complication because of obstructed uropathy like 
vasical calculus and recurrent urinary tract infection. 
 Patient had more than 30%post void urine pf total 
pre void urine. 
Subjective Parameters 
 Subjective parameters were considered 
according to international prostate symptoms scores. 
This would be as per International Prostate Symptom 
Score.
Table 1: Subjective Parameters and Gradations 
 Not at All Less than 1 time Less than ½ 
time 
About ½ 
Time 
More than ½ 
time 
Almost Always 
 0 1 2 3 4 5 
Complete 0 1 2 3 4 5 
Emptying 0 1 2 3 4 5 
Frequency 0 1 2 3 4 5 
Intermittency 0 1 2 3 4 5 
Urgency 0 1 2 3 4 5 
weak streaming 0 1 2 3 4 5 
Straining 0 1 2 3 4 5 
Nocturnal 0 1 2 3 4 5 
Micturation 0 1 2 3 4 5 
Table 2: Criteria According to Reduction in IPSS Score 
IPSS Score Criteria 
1- 10 Mild 
11- 20 Moderate 
21- 30 Severe 
OBJECTIVE PARAMETERS 
1. Volume of prostate in USG  
2. Residual urine in USG before and after treatment  
1. Trial group 
Number of patient: 15 
Treatment: Patala kshar 
Dose: 500mg B.D 
2. Control group 
Number of patient: 15 
Treatment: Tamsulosin hydrochloride 0.4 mg H.S 
Dose: 0.4 mg H.S 
Follow up 
 Follow up was taken on 0th, 7th and 15th day which was recorded in tubular form. 
OBSERVATIONS 
During study we have come across following observations. Total no. of patients- 30 
Observation and results 
Age incidence:  
Table 3: Age Group are taken in the study 
Age Group  Trial Group Control Group 
Frequency Percentage Frequency Percentage 
50-60  4 26.7 5 33.3 
60-70  11 73.3 8 53.3 
70-80  0 0 2 13.3 
TOTAL  15 100 15 100 
• IN TRIAL GROUP 
 In 50-60 yrs age group patients are 4(26.7%), in 60-70 age group 11(73.3%), in 70-80 age group 0(0%). 
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• IN CONTROL GROUP 
 In 50-60 yrs age group patients are 5(33.3%), in 60-70 age group 8(53.3%), in 70-80 age group 2(13.3%).  
Occupational Distribution 
 In both groups more incidence of BPH present in farmer class. Least occurrence in service class 
Table 4: Occupational Distribution of Patients in the study 
Occupation  
Trial Group Control Group 
Frequency Percentage Frequency Percentage 
Driver  2 13.3 2 13.3 
Farmer  6 40 6 40 
Service  2 13.3 1 6.7 
Labour (other)  5 33.3 6 40 
Total  15 100 15 100 
Table 5: Upashaya Anupashaya According to Incomplete Emptying 
Incomplete Emptying Mean Wilcoxon Signed 
Rank W 
P-Value % Effect Result 
B.T. A.T. 
Trial Group  4.27 2.67 -3.448a .001 37.5 Significant 
Control Group  4.60 2.87 -3.578a .000 37.7 Significant 
In case of Incomplete Emptying in both groups p value is <0.05 so results are significant in both. But more significant in 
control group. 
Table 6: Upashaya Anupashaya According To Frequency 
FREQUENCY 
Mean Wilcoxon Signed 
Rank W 
P-Value % Effect Result 
B.T. A.T. 
Trial Group  4.20 2.53 -3.407a .001 39.7 Significant 
Control Group  4.20 2.80 -3.535a .000 33.3 Significant 
In frequency symptom in both groups p value is <0.05 so results are significant in both. But more significant in control 
group. 
Table 7: Upashaya Anupshaya According to Intermittency 
INTERMITTENCY 
Mean Wilcoxon Signed 
Rank W 
P-Value % Effect Result 
B.T. A.T. 
Trial Group  3.87 2.07 -3.460a .001 46.6 Significant 
Control Group  3.40 2.00 -3.109a .002 41.2 Significant 
In intermittency symptom in both groups p value is <0.05 so results are significant in both. But more significant in trial 
group. 
Table 8: Upashaya Anupshaya According To Urgency 
URGENCY 
Mean Wilcoxon Signed 
Rank W 
P-Value % Effect Result 
B.T. A.T. 
Trial Group  4.13 2.13 -3.349a .001 48.4 Significant 
Control Group  4.40 2.40 -3.499a .000 45.5 Significant 
In urgency symptom in both groups p value is <0.05 so results are significant in both. But more significant in control 
group. 
Table 9: Upshaya anupshaya according to weak stream 
WEAK STREAM 
Mean Wilcoxon Signed 
Rank W 
P-Value % Effect Result 
B.T. A.T. 
Trial Group  3.47 1.93 -3.236a .001 44.2 Significant 
Control Group  3.40 2.13 -3.069a .002 37.3 Significant 
In weak stream symptom in both groups p value is <0.05 so results are significant in both. But more significant in trial 
group. 
Table 10: Upshaya Anushaya According To Straining 
STRAINING 
Mean Wilcoxon Signed 
Rank W 
P-Value % Effect Result 
B.T. A.T. 
Trial Group  3.53 1.73 -3.108a .002 50.9 Significant 
Control Group  4.07 1.93 -3.448a .001 52.5 Significant 
In straining symptom in both groups p value is <0.05 so results are significant in both. But more significant in control 
group. 
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Table 11: Upashay And Anupshay According To Nocturia 
NOCTURIA 
Mean Wilcoxon Signed 
Rank W 
P-Value % Effect Result 
B.T. A.T. 
Trial Group  3.87 1.93 -3.275a .001 50.0 Significant 
Control Group  4.07 1.87 -3.434a .001 54.1 Significant 
In nocturia symptom in both groups p value is <0.05 and equal in both groups so results are equally significant 
Table 12: Prostate Volume In Both Groups 
Prostate Volume 
Mean 
t-Value P-Value Result 
B.T. A.T. 
Patala  30.87 30.27 2.073 .057 Not Significant 
Tamsulosin  29.47 29.47 .000 1.000 Not Significant 
Table 13: USG Residual 
USG Residual 
Mean 
t-Value P-Value Result 
B.T. A.T. 
Patala  148.87 135.80 1.247 .233 Not Significant 
Tamsulosin  95.73 135.80 1.538 .146 Not Significant 
Table 14: Reduction in IPSS Score after treatment for 15 Days in Both Group 
IPSS 
Mean 
t-Value P-Value Result 
B.T. A.T. 
Patala  27.47 14.87 11.896 .000 Significant 
Tamsulosin  26.87 13.67 17.150 .000 Significant 
For Between Group Comparison we have used 
unpaired t-test 
 From Above table we can observe that, P-Value is 
greater than 0.05 hence we conclude that there is no 
significant difference between Patala and Tamsulosin in 
these three criterias.  
Results: Both methods show about same significant 
results. 
DISCUSSION 
 In Benign Prostatic Hypertrophy there is an 
evidence of intermittent micturation. This is considered to 
be there as a result of Bladder neck obstruction. Our 
studies reveal that, In intermittency symptom in both 
groups p value is <0.05 so results are significant in both. 
But more significant in trial group. Thus Patala kshar is 
proved to be effective in Intermittency so as Tamsulosine 
Hydrochloride. Tamsulosine has action on alpha 1 
receptors hence relaxes detrusor muscle hence effective in 
relieving intermittency. Patala kshar is believed to have 
same action on detrusor muscle as it practically relieves 
intermittency. Urgency in prostate enlargement is 
common. There is sort of incontinence in such patients. 
The urge of micturation is uncontrollable and sometimes 
patient can’t hold the urine till he reaches the toilet. Due to 
continuous irritation of bladder and frequency, the 
sphincter muscles of bladder get affected. The drug used in 
Patala kshar is Bastishodhan, Rasayana and tonic to 
urinary bladder. These properties are helpful in 
strengthening of urinary bladder. This improves the 
symptom urgency.  
 In urgency symptom in both groups p value is 
<0.05 so results are significant in both. But more 
significant in control group. Hence tamsulosin is more 
effective than Patala kshar in this symptom. 
 This symptom is found in prostate enlargement. 
According to modern science, if there is chronic residual 
urine, for long duration, it may cause cystitis changes in 
bladder. This causes Sakashta Mutra P:ravruti. If amount of 
residual urine is decreased, patient gets relief from the 
symptom. In straining symptom in both groups p value is 
<0.05 so results are significant in both. But more 
significant in control group. .Hence Tamsulosin 
hydrochloride is more effective than Patala Kshar in this 
symptom. 
 As the amount of residual urine is decreased, 
patient gets relief from frequency of micturation and can 
sleep peacefully. This reduces the evidence of Nakta 
Mutrata. In nocturia symptom in both groups p value is 
<0.05 and equal in both groups so results are equally 
significant. 
 In Prostate enlargement, the stream of urine is 
very weak. The drugs used gives strength to urinary 
bladder. Thus, increase in the strength of urinary system, 
the force of urine improved. In straining symptom in both 
groups p value is <0.05 so results are significant in both. 
But more significant in control group. 
 The patient group treated by experimental drug 
got good results on this symptom. This was the first 
symptom to disappear after starting the treatment. In 
Prostate enlargement there is always residual urine in 
bladder. Due to this residual and irritation to bladder, the 
frequency of micturation is increased. 
The drugs Patalakshar and Tamsulosin Hcl helps 
in decreasing the quantity of residual urine and irritation 
of bladder leading to relief in symptom Muhurmuhu Mutra 
Pravruti. 
 In frequency symptom in both groups p value is 
<0.05 so results are significant in both. But more 
significant in control group. 
 In Context with Residual urine, both Patala kshar 
and Tamsulosine Hcl are equally effective.  
 From the practical study we interpret that there is 
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not any Reduction in size of Enlarged Prostate with 
treatment by both Patala kshar and Tamsulosine 
hydrochloride. Hence we say that both Patala kshar and 
Tamsulosine hydrochloride are effective at all in Reducing 
size of prostate. 
 This is an internationally standardized criteria 
for judging symptoms throughout practical observations. 
Conclude that there is significant reduction in IPSS score 
both by Patala kshar and Tamsulosine hydrochloride. 
The point to be desired is that both Patala kshar 
and Tamsulosine hydrochloride are equally efficient in 
Reducing International Prostate symptom score. 
Mode of Action of Patala kshar 
1) Shodhan chikitsa 
According to Acharya Susrut Kshar shows Shodhan 
karma described in Su.su 11/5 due to this it decreases 
symptoms intermittency and weak stream, straining 
and incomplete emptying 
2) Lekhana Chikitsa 
Katu ushna and Tikshna dravyas bring about scrapping 
of tissue which is enlarged. Ksharas are Ushna and 
Tikshna in Guna hence bring about scrapping of the 
tissue. Ksharas are famous for their Lekhan karma. 
Kshar is Katu Ushna and Tikshna hence by these Gunas 
it brings about Lekhan and indirectly reduced the 
symptoms like urgency frequency. 
3) In Vatasthilla kapha and Vata doshas prakopa occurs 
and Patala kshar having property “Tridosh-
ghantvatvata”3 so it acts on Vata and Kapha both 
Doshas. Hence decreases the associated symptoms. 
4) Patala Kshar having Bhedhan property due to this it 
reduces the size of prostate in BPH. 
5) In BPH because of obstruction most of the time urine 
infection occurs as well as irritable symptoms like 
frequency, urgency, nocturia get worsen. Because of 
alkaline ph of Kshar urine pH gets alkaline so irritable 
symptoms get reduce. 
6) Due to anti-inflammatory effect of ETHANOL extract 
which is present in Patala Kshar it reduces the size of 
prostate and associated symptoms.4 
CONCLUSION 
 From whole statistical analysis we can conclude 
that Tamsulosin is more efficient than Patala kshar in 
present study. Though statistically Patala Kshara has less 
efficacy than Tamsulosin, the size of prostate was reduced 
in 15 days study(Which was statistically insignificant), So 
we hope that with increasing duration and by adding some 
more drugs will give good effects. Thus from above 
observations we can conclude the Patala Kshar can be the 
choice of drug in conservative Treatment of benign 
Prostatic Hypertrophy to reduce the symptoms mostly in 
Grade I and Grade II prostatomegaly by increasing 
duration of treatment course. 
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